Article

table test

 

 

 

100
200
300
400
500
600
700
800
900

 

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Leqvio Shows Clinically Meaningful LDL-C Goal Attainment in Patients with Hypercholesterolemia in Phase IV Trial
September 4th 2025

Leqvio Shows Clinically Meaningful LDL-C Goal Attainment in Patients with Hypercholesterolemia in Phase IV Trial

Don Tracy, Associate Editor
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
September 4th 2025

ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains

Andy Studna, Senior Editor
Merck’s Oral PCSK9 Inhibitor Demonstrates Efficacy in Hypercholesterolemia
September 4th 2025

Merck’s Oral PCSK9 Inhibitor Demonstrates Efficacy in Hypercholesterolemia

Don Tracy, Associate Editor
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
September 4th 2025

ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials

Andy Studna, Senior Editor
Roche, Alnylam Launch Phase III Trial for Novel RNAi Therapeutic in Uncontrolled Hypertension
September 4th 2025

Roche, Alnylam Launch Phase III Trial for Novel RNAi Therapeutic in Uncontrolled Hypertension

Don Tracy, Associate Editor
Merck’s Verquvo Fails to Meet Primary Endpoint in Phase III Trial for Chronic Heart Failure and Reduced Ejection Fraction
September 4th 2025

Merck’s Verquvo Fails to Meet Primary Endpoint in Phase III Trial for Chronic Heart Failure and Reduced Ejection Fraction

Don Tracy, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.